BN40697 - A study to look at tominersen safety over 15 months in people with Huntington’s disease
An Open-Label Extension Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139)
Neurodegenerative Disorder Huntington Disease (HD)
For the latest version of this information please go to www.forpatients.roche.com